Related Experiment Videos
NRMI and current treatment patterns for ST-elevation myocardial infarction.
1Harvard Medical School, Boston Mass, USA. mgibson@perfuse.org
American Heart Journal
|October 30, 2004
Summary
The National Registry of Myocardial Infarction (NRMI) has tracked over 2.2 million patients since 1990. Discoveries from this large acute myocardial infarction (AMI) registry have improved patient care, particularly for ST-segment elevation cases.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- The National Registry of Myocardial Infarction (NRMI) is a longstanding, extensive database tracking acute myocardial infarction (AMI).
- Established in 1990, NRMI has involved 1600 hospitals and over 2.2 million patients.
- Four NRMI studies have been conducted, with one currently active.
Purpose of the Study:
- To present key findings from the NRMI registry.
- To highlight advancements in understanding ST-segment elevation myocardial infarction (STEMI).
- To demonstrate the impact of NRMI discoveries on patient care.
Main Methods:
- Longitudinal data collection from a large cohort of acute myocardial infarction (AMI) patients.
- Analysis of data from 1600 participating hospitals.
- Focus on ST-segment elevation myocardial infarction (STEMI) outcomes.
Main Results:
- Identification of critical factors related to ST-segment elevation myocardial infarction (STEMI).
- Demonstration of significant contributions to improving treatment protocols.
- Insights derived from a dataset exceeding 2.2 million patients.
Conclusions:
- The NRMI registry has been instrumental in advancing the care of acute myocardial infarction (AMI) patients.
- Key discoveries regarding ST-segment elevation have directly translated into improved clinical practice.
- Continued participation and data analysis are vital for ongoing improvements in cardiovascular medicine.